Journal of Medical Economics, Volume 17, Issue 8 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 17, Issue 8 (2014)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Volume 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Endocrinology: Original article

Article
Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer
Tanya G.K. Bentley, Brock E. Schroeder, Catherine A. Schnabel, Mark G. Erlander, Wendy C. Hsiao, Jesse D. Ortendahl & Michael S. Broder
Pages: 527-537
Published online: 14 May 2014
AbstractforCost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer | Full Text | References | PDF (814.2 KB) | Supplemental
  • 729 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Oncology: Original articles

Article
Targeted erlotinib for first-line treatment of advanced non-small cell lung cancer: a budget impact analysis
Preeti S. Bajaj, David L. Veenstra, Hans-Peter Goertz & Josh J. Carlson
Pages: 538-546
Published online: 12 May 2014
AbstractforTargeted erlotinib for first-line treatment of advanced non-small cell lung cancer: a budget impact analysis | Full Text | References | PDF (205.4 KB)
  • 1117 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Regression analysis of indicating multiple incremental cost-effectiveness ratios for non-small cell lung cancer treatment
Naohiro Nakahara & Isao Kamae
Pages: 547-554
Published online: 29 May 2014
AbstractforRegression analysis of indicating multiple incremental cost-effectiveness ratios for non-small cell lung cancer treatment | Full Text | References | PDF (247.8 KB)
  • 550 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology: Original article

Article
Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis
Jeffrey R. Curtis, Vernon F. Schabert, Jason Yeaw, Jonathan R. Korn, Caroleen Quach, David J. Harrison, Huifeng Yun, George J. Joseph & David Collier
Pages: 555-566
Published online: 14 May 2014
AbstractforUse of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis | Full Text | References | PDF (165.2 KB)
  • 1116 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access

Psychiatry: Original article

Article
Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States
Leslie Citrome, Siddhesh A. Kamat, Christophe Sapin, Ross A. Baker, Anna Eramo, Jesse Ortendahl, Benjamin Gutierrez, Karina Hansen & Tanya G. K. Bentley
Pages: 567-576
Published online: 12 May 2014
AbstractforCost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States | Full Text | References | PDF (234.9 KB)
  • 1984 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access

Gastroenterology: Original article

Article
The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population
Annie Guerin, Robyn T. Carson, Barbara Lewis, Donald Yin, Michael Kaminsky & Eric Wu
Pages: 577-586
Published online: 28 May 2014
AbstractforThe economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population | Full Text | References | PDF (141.4 KB)
  • 881 Views
  • 42 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular: Original articles

Article
Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin
T. Lanitis, F. E. Cotté, A. F. Gaudin, I. Kachaner, T. Kongnakorn & I. Durand-Zaleski
Pages: 587-598
Published online: 29 May 2014
AbstractforStroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin | Full Text | References | PDF (565.9 KB) | Supplemental
  • 5734 Views
  • 51 CrossRef citations
  • 0Altmetric
Free Access
Article
A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation
H. L. Cameron, L. M. Bernard, V. S. Garmo, J. B. Hernandez & A. W. Asgar
Pages: 599-615
Published online: 30 May 2014
AbstractforA Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation | Full Text | References | PDF (437.3 KB)
  • 1588 Views
  • 25 CrossRef citations
  • 0Altmetric
Free Access

Explore articles